Concepedia

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

Lauren M. Byrne, Filipe B. Rodrigues, Kaj Blennow, Alexandra Dürr, Blair R. Leavitt, Raymund A.C. Roos, Rachael I. Scahill, Sarah J. Tabrizi, Henrik Zetterberg, Douglas R. Langbehn,

The Lancet Neurology · 2017 · 350 citations · 23 references

DOIFull text

Open access

Abstract

Medical Research Council, GlaxoSmithKline, CHDI Foundation, Swedish Research Council, European Research Council, Wallenberg Foundation, and Wolfson Foundation.

References

23

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

Sarah J. Tabrizi, Douglas R. Langbehn, Blair R. Leavitt et al. · The Lancet Neurology · 2009 · 959 citations

, , +8

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data

Sarah J. Tabrizi, Rachael I. Scahill, Gail Owen et al. · The Lancet Neurology · 2013 · 822 citations

, , +6

Neurofilament light chain

Ching‐Hua Lu, Corrie Macdonald‐Wallis, Elizabeth Gray et al. · Neurology · 2015 · 532 citations · Full text

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

Lars Rosengren, Jan‐Erik Karlsson, Jan‐Olof Karlsson et al. · Journal of Neurochemistry · 1996 · 493 citations

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

Johanna Gaiottino, Niklas Norgren, Ruth Dobson et al. · PLoS ONE · 2013 · 478 citations · Full text